Bibliography
Export 40 results:
Filters: Author is Hanaway,M. J. [Clear All Filters]
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant. 2005;5(2):356-65.
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant. 2005;5(4 Pt 1):775-80.
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):956-7.
De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. Transplant Proc. 2005;37(2):960-1.
Donor kidneys with small renal cell cancers: can they be transplanted? Transplant Proc. 2005;37(2):581-2.
Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection. Transplant Proc. 2005;37(2):798-9.
Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation. Transplant Proc. 2005;37(2):812-3.
Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens. Transplant Proc. 2005;37(2):809-11.
Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study. Clin Transplant. 2005;19(1):102-9.
Laparoscopic living donor nephrectomy for kidneys with multiple arteries. Transplant Proc. 2005;37(2):629-30.
Laparoscopic right living donor nephrectomy. Transplant Proc. 2005;37(2):631-2.
Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc. 2005;37(2):1243-4.
Pilot study of early corticosteroid elimination after pancreas transplantation. Transplant Proc. 2005;37(2):1287-8.
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc. 2005;37(2):954-5.
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):958-9.
Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):962-3.
Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum. 2004;47(11):1898-903.
Donor transmitted malignancies. Ann Transplant. 2004;9(1):53-6.
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation. 2004;78(11):1676-82.
Posttransplant malignancy. Prog Transplant. 2004;14(3):193-200.
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78(7):972-7.
Right donor nephrectomy: a comparison of hand-assisted transperitoneal and retroperitoneal laparoscopic approaches. Transplantation. 2004;77(4):521-5.